Keywords: Johnson & Johnson, Ortho-McNeil, Risperdal, Recall, Anti-psychotic, Manufacturing problems

Another recall for J&J, as Ortho-McNeil reports odor problem with Risperdal

Article | 20 June 2011

Print This

Ortho-McNeil-Janssen Pharmaceuticals, a unit of US health care giant Johnson & Johnson (NYSE: JNJ), which has been plagued by a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in